Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever ...
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for ...
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
3hon MSN
A higher dividend yield is nice because it allows you to collect more dividend income on every dollar you invest in a stock.
A hospital trust has become the first in the UK to fit patients with a new leadless pacemaker. Northampton General Hospital ...
OSF HealthCare Saint Anthony’s Health Center is proud to announce it has received the Sustainability Champion Award in ...
Shares of Medtronic PLC MDT rallied 2.27% to $89.94 Friday, on what proved to be an all-around poor trading session for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback